Lipotec’s Eyeseryl wins award

Eyeseryl, one of the latest peptides launched by Lipotec, recently received the New Technology Award 2005 at the HBA (Health & Beauty America) Conference & Exhibition which took place in New York.

Eyeseryl is a synthetic tetrapeptide with antioedema properties specifically designed to reduce puffiness around the eyes. Eyeseryl was officially launched at PCIA 2005 in Bangkok and has quickly made a significant, positive impact. It is soon expected to become a worldwide reference, especially for cosmetic products developed for use around the eye. Following its worldwide success with its anti-wrinkle hexapeptide Argireline, Lipotec has continued developing synthetic peptides for cosmetic use – and Eyeseryl is the latest example.

Latest Issues

in-cosmetics Korea 2025

COEX, Seoul
2nd - 4th July 2025

Breakthrough Science & Claims Testing - The SCS Annual Conference

Royal College of Surgeons of England, London
2 - 3 July